By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Astellas Pharma US 

1 Astellas Way

Northbrook  Illinois  60062  U.S.A.
Phone: 800-695-4321 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals

Collaborations

Gilead 

Gilead (Seattle, WA) 





Company News
Astellas Pharma US Release: Mirabegron As Add-On Treatment To Solifenacin Therapy Demonstrated Superior Results To Solifenacin Monotherapy In BESIDE Trial 5/18/2015 6:35:05 AM
Astellas Pharma US Release: CRESEMBA (Isavuconazonium Sulfate) Data To Be Presented At The European Congress Of Clinical Microbiology And Infectious Diseases 4/24/2015 12:30:24 PM
Astellas Pharma US And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics 4/22/2015 11:05:38 AM
Astellas Pharma US Teams Up With The Chris Klug Foundation On The Bounce Back Award To Recognize Extraordinary Transplant Recipients 4/2/2015 7:33:41 AM
Astellas Pharma US Release: New Enzalutamide Data To Be Presented In Late Breaking News Plenary Session At European Association Of Urology Congress 3/17/2015 10:04:13 AM
Astellas Pharma US And BlackDoctor.org (BDO) Team Up To Offer Health Education At The 2015 CIAA Tournament Fan Fest 2/20/2015 1:37:13 PM
Astellas Pharma US Release: XTANDI™ (Enzalutamide) Now Approved In Europe For The Treatment Of Men With Metastatic Castration-Resistant Prostate Cancer Who Are Chemotherapy-Na├»ve 12/2/2014 9:16:16 AM
Medivation, Inc. (MDVN) And Astellas Pharma US Announce Phase 3 Study Of Enzalutamide in Men With High-Risk, Hormone-Sensitive, Non-Metastatic Prostate Cancer That Has Recurred Following Definitive Local Therapy 10/31/2014 12:45:31 PM
Astellas Pharma US Teams Up With USA Rugby And Men's Health Network To Encourage Chicagoans To Answer The Challenge For Better Health 10/15/2014 8:13:43 AM
Brian McLellan Promoted To President Of Astellas Pharma US 10/2/2014 8:46:16 AM
123456789
//-->